Heligan Corporate Finance Advises Bromsgrove based IPP Group on cross-border transaction

Heligan Corporate Finance ("HCF") is pleased to announce that it has advised the shareholders of IPP Group on its sale to Indutrade, an international technology and industrial business group in Sweden.

Founded in 1976, IPP has offices in Bromsgrove, UK and Cork, Ireland, and has sales of approximately €17m.  IPP is a specialist provider of manufacturing equipment and consumables to the pharmaceutical, medical device, and electronic sectors in the UK and Ireland. 

Bo Annvik, President & CEO of Indutrade commented: 

“IPP has a proven track record of sustainable profitable growth driven by its high technical expertise and focus on customer service. The company also aligns well culturally with Indutrade, and I’m pleased to welcome them to the Group.”

Jack Daly, MD of IPP added: 

“IPP has grown significantly in recent years, based on a foundation of putting the customer at the forefront of the business model whilst supplying innovative solutions. This transaction marks the next step in IPP’s journey, and I look forward to working with Indutrade to continue our growth.  The team at Heligan were hands-on throughout the process and I’m grateful for their guidance and positive approach.”   

Matt Croker, M&A Director at Heligan added: 

“It has been a pleasure to work with Jack and the team on this transaction.  Being part of Indutrade is another step forward for IPP in what has been an impressive few years of growth.  It has been an enjoyable transaction to be part of and aided by the collaborative approach taken by both IPP and Indutrade.” 

Matt Croker and Eleanor Smith from Heligan provided M&A advice to IPP.  

The financial terms of the transaction are not disclosed.  The transaction is contingent on receiving regulatory approvals.